Arkéa Capital

Corporate VC Brest, France · Founded 1982

Arkéa Capital is the private equity arm of Crédit Mutuel Arkéa, backing French startups, SMEs, and mid-market companies as a minority investor since 1982. Sector-agnostic but explicitly includes healthcare and life sciences in their scope.

About Arkéa Capital

Arkea Capital is the private equity arm of Credit Mutuel Arkea, a regional French banking group, with offices anchored in Brest. Founded in 1982, it operates as a long-horizon minority investor across French SMEs, mid-market companies, and selective venture-stage opportunities, with healthcare and life sciences explicitly within scope.

The thesis is sector-agnostic but built around patient capital, minority co-investment, and relationships with established French entrepreneurs. For healthcare founders, that translates to interest in care delivery, tech-enabled services, and health IT companies with proven business models, French commercial footprints, and a path to scale in domestic and adjacent European markets rather than venture-style global ambition. Portfolio companies are not disclosed in the input record, so founders should expect to ask for relevant healthcare references during early conversations. The firm’s stated transaction types are minority, co-invest, and growth equity, which matches how a corporate-affiliated French PE arm typically engages.

Disclosed check size is $5M to $25M across Series A, Series B, and growth, with French-only geographic scope. That positions Arkea Capital firmly as a growth-equity and late-venture player rather than an early seed lead. Founders pre-revenue or pre-Series A are out of scope; founders with EUR 3M or more in revenue and a clean French operating story are squarely in scope.

Named team members are not provided in the source record. The firm’s equipe page is the right reference for partner identification before outreach.

Approach Arkea Capital when you are a French healthcare services, tech-enabled services, or health IT founder with established revenue, profitable or near-profitable unit economics, and a credible plan for organic and inorganic growth across France and France-adjacent markets. They are not the right call for early seed, US-only plays, or aggressive cash-burn growth stories that depend on US venture capital follow-on dynamics. The right entry is via a French banking or M&A advisor who knows Credit Mutuel Arkea, or through a French portfolio founder. When pitching, lean into governance maturity, board readiness, and a clear minority-investor partnership model, because that is the shape of capital Arkea provides. Founders seeking a control buyer or a fully venture-style growth lead should look elsewhere.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Other portfolio companies

Companies in Arkéa Capital's portfolio not currently in our directory.

Team

Marc Briu00e8re
Pru00e9sident du Directoire
LinkedIn
Anne Garans
Directrice Associu00e9e
LinkedIn
Cyril Lamblard
Directeur des Investissements
LinkedIn

Pitch / review this investor

Have you raised from Arkéa Capital? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.